Connect with us


A Study Predicts a Twofold Increase in New Prostate Cancer Cases by 2040



Prostate cancer cases worldwide are projected to more than double over the next 20 years as less affluent countries begin to experience the aging population phenomenon already seen in wealthier nations,
as revealed in a recent Lancet report.

The medical journal reported that the annual number of new cases is estimated to climb from 1.4 million in 2020 to 2.9 million by 2040, reflecting demographic shifts.

Researchers associated with the study attributed the surge in cases to longer life expectancies and alterations in the global age distribution.

Prostate cancer ranks as the most prevalent cancer in men, constituting around 15% of male cancer cases. It typically manifests after age 50 and becomes more prevalent with advancing age.

With improved life expectancies in developing nations, the incidence of prostate cancer is also on the rise, according to the researchers.

They emphasized that unlike lung cancer or heart diseases, public health policies have limited influence on the prevalence of prostate cancer.

Hereditary factors are significantly less controllable compared to smoking, a leading contributor to lung cancer. While a correlation with body weight has been identified, its direct impact on prostate cancer remains uncertain.

The researchers also highlighted the importance for health authorities to promote early screening in developing countries due to the disease often being diagnosed at later stages, hindering effective treatment.